Recruiting Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers NCT04886531 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more Locations University of Illinois Cancer Center — Chicago, Illinois, United States University of Rochester Medical Center — Rochester, New York, United States Penn State Cancer Institute — Hershey, Pennsylvania, United States University of Wisconsin — Madison, Wisconsin, United States View Trial Details
Recruiting PRE-I-SPY Phase I/Ib Oncology Platform Program NCT05868226 Conditions Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more Locations The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center — Birmingham, Alabama, United States Moffitt Cancer Center — Tampa, Florida, United States The University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois, United States UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital — New Lenox, Illinois, United States View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Supporting Health Including Endocrine Treatment for Long Duration NCT07482384 Conditions Breast Cancer, Breast Cancer - Female, Breast Carcinoma, +8 more Locations Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
